Address Information


E-mail CVBT

Investor Inquiry

Scientific Inquiry

General and Press Inquiries

Clinical Trial Inquiries



   
Site Map  
 

About CVBT
Corporate Profile  
Target Market 
Business Strategy
Our Story
Chairman's Message
Mission Statement
Officers & Key Personnel

Technology
Research & Development
      Heart

      Brain

      Chronic Back Pain

      Kidney

      Intestinal Ischemia

      Diabetic Neuropathy

      Legs

      Wound Healing
Scientific Overview
Scientific Presentations
Scientific Advisory Board 
Clinical Studies
Clinical Trial Participation
Clinical Trial Sites
Pre-Clinical Studies
Product Pipeline
Scientific Reports

Investors
Stock Quote
Historical Stock Chart
Press Releases
Annual Report
Management Presentations
Event Calendar
Shareholder Services
Corporate Governance
SEC Filings

News/Events
Press Releases

Media Coverage 
Scientific Presentations
Investor Events

Contact Us
Address Information

E-mail CVBT
Investor Inquiry
Scientific Inquiry
General and Press Inquiries
Clinical Trial Inquiries

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership